Perceptive Advisors OM Position
ActivePerceptive Advisors held their position in Outset Medical, Inc. (OM) in Q4 2025, holding $3.1M worth of shares across 833,333 shares.
The position was first reported in Q1 2025 and has been tracked across 4 quarterly 13F filings.
Perceptive Advisors OM Position History
Frequently Asked Questions
Does Perceptive Advisors own OM?
Yes. As of Q4 2025, Perceptive Advisors holds 833,333 shares of Outset Medical, Inc. (OM) valued at $3.1M. This data comes from their SEC 13F filing.
How many hedge funds own OM?
1 specialist biotech hedge fund currently holds OM. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Perceptive Advisors first buy OM?
Perceptive Advisors's position in OM was first reported in Q1 2025. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Perceptive Advisors's OM position increasing or decreasing?
Perceptive Advisors held their OM position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
OMCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Perceptive AdvisorsPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →